{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:17:16Z","timestamp":1788430636398,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Research Program of the Yangtze River Delta Science and Technology Innovation Community","award":["2025CSJGG02500"],"award-info":[{"award-number":["2025CSJGG02500"]}]},{"name":"Jiangsu Shuangchuang Talent Program","award":["JSSCRC20250445"],"award-info":[{"award-number":["JSSCRC20250445"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transgenic Res"],"DOI":"10.1007\/s11248-026-00510-y","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:42:10Z","timestamp":1788428530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction and evaluation of an independently generated transgenic mouse model carrying mutated human HRAS genes for short-term carcinogenicity assessment"],"prefix":"10.1007","volume":"35","author":[{"given":"Wen","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"510_CR1","doi-asserted-by":"publisher","first-page":"jcs258932","DOI":"10.1242\/jcs.258932","volume":"135","author":"N Andr\u00e9s-S\u00e1nchez","year":"2022","unstructured":"Andr\u00e9s-S\u00e1nchez N, Fisher D, Krasinska L (2022) Physiological functions and roles in cancer of the proliferation marker Ki-67. J Cell Sci 135:jcs258932. https:\/\/doi.org\/10.1242\/jcs.258932","journal-title":"J Cell Sci"},{"key":"510_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41573-025-01182-9","volume":"24","author":"M Beilmann","year":"2025","unstructured":"Beilmann M, Adkins K, Boonen HCM, Hewitt P, Hu W, Mader R, Moore S, Rana P, Steger-Hartmann T, Villenave R, van Vleet T (2025) Application of new approach methodologies for nonclinical safety assessment of drug candidates. Nat Rev Drug Discov 24:705\u2013725. https:\/\/doi.org\/10.1038\/s41573-025-01182-9","journal-title":"Nat Rev Drug Discov"},{"key":"510_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00335-007-9056-y","volume":"18","author":"KJ Chandler","year":"2007","unstructured":"Chandler KJ, Chandler RL, Broeckelmann EM, Hou Y, Southard-Smith EM, Mortlock DP (2007) Relevance of BAC transgene copy number in mice: transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression. Mamm Genome 18:693\u2013708. https:\/\/doi.org\/10.1007\/s00335-007-9056-y","journal-title":"Mamm Genome"},{"key":"510_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/334119a0","volume":"334","author":"JB Cohen","year":"1988","unstructured":"Cohen JB, Levinson AD (1988) A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 334:119\u2013124. https:\/\/doi.org\/10.1038\/334119a0","journal-title":"Nature"},{"key":"510_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1214\/ss\/1177012993","volume":"3","author":"DA Freedman","year":"1988","unstructured":"Freedman DA, Zeisel H (1988) From mouse-to-man: the quantitative assessment of cancer risks. Stat Sci 3:3\u201328. https:\/\/doi.org\/10.1214\/ss\/1177012993","journal-title":"Stat Sci"},{"key":"510_CR6","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1073\/pnas.77.12.7380","volume":"77","author":"JW Gordon","year":"1980","unstructured":"Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. P Natl Acad Sci Usa 77:7380\u20137384. https:\/\/doi.org\/10.1073\/pnas.77.12.7380","journal-title":"P Natl Acad Sci Usa"},{"key":"510_CR7","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (1995) Guideline on the Need for Carcinogenicity Studies of Pharmaceuticals S1A. URL. https:\/\/database.ich.org\/sites\/default\/files\/S1A_Guideline.pdf. Accessed from 31 Dec 2025"},{"key":"510_CR8","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2022) Testing for Carcinogenicity of Pharmaceuticals S1B(R1). URL. https:\/\/database.ich.org\/sites\/default\/files\/S1B-R1_FinalGuideline_2022_0719.pdf. Accessed from 31 Dec 2025"},{"key":"510_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1293\/tox.16.267","volume":"16","author":"H Kanno","year":"2003","unstructured":"Kanno H, Tanakamaru Z, Ishimura Y, Kandori H, Yamasaki H, Sasaki S, Hikari B, Pharmaceutical RD, Drug SRC, Takeda CI (2003) Historical background data in CB6F1-Tg-rasH2 mice and CB6F1-nonTg-rasH2 mice over a 26-week experimental period. J Toxicol Pathol 16:267\u2013274. https:\/\/doi.org\/10.1293\/tox.16.267","journal-title":"J Toxicol Pathol"},{"key":"510_CR10","first-page":"249","volume":"22","author":"M Katsuki","year":"1991","unstructured":"Katsuki M, Ando K, Saitoh A, Doi S, Kimura M, Takahashi R, Hasegawa T, Yokoyama M, Nomura T, Izawa M (1991) Chemically induced tumors in transgenic mice carrying prototype human c-Ha-ras genes. Princess Takamatsu Symp 22:249\u2013257","journal-title":"Princess Takamatsu Symp"},{"key":"510_CR11","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li LT, Jiang G, Chen Q, Zheng JN (2015) Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 11:1566\u20131572. https:\/\/doi.org\/10.3892\/mmr.2014.2914","journal-title":"Mol Med Rep"},{"key":"510_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.envint.2019.04.067","volume":"128","author":"F Madia","year":"2019","unstructured":"Madia F, Worth A, Whelan M, Corvi R (2019) Carcinogenicity assessment: addressing the challenges of cancer and chemicals in the environment. Environ Int 128:417\u2013429. https:\/\/doi.org\/10.1016\/j.envint.2019.04.067","journal-title":"Environ Int"},{"key":"510_CR13","doi-asserted-by":"publisher","first-page":"1530086885","DOI":"10.1177\/23978473231173093","volume":"7","author":"RR Maronpot","year":"2023","unstructured":"Maronpot RR, Koyanagi M, Hayashi S, Mahapatra D, Nishino M, Iniwa M (2023) Gardenia blue is not carcinogenic in the rasH2 mouse. Toxicol Res Appl 7:1530086885. https:\/\/doi.org\/10.1177\/23978473231173093","journal-title":"Toxicol Res Appl"},{"key":"510_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/oemed-2023-109277","volume":"81","author":"DRS Middleton","year":"2024","unstructured":"Middleton DRS, Wedekind R, Hall AL, Suonio E, DeBono N, Vermeulen R, Fritschi L, Stewart PA, Schubauer-Berigan MK (2024) Critical reviews of exposure assessment in carcinogenic hazard identification: the IARC monographs experience. Occup Environ Med 81:366\u2013372. https:\/\/doi.org\/10.1136\/oemed-2023-109277","journal-title":"Occup Environ Med"},{"key":"510_CR15","doi-asserted-by":"publisher","first-page":"149014","DOI":"10.1016\/j.gene.2024.149014","volume":"934","author":"K Mogi","year":"2025","unstructured":"Mogi K, Tomita H, Yoshihara M, Kajiyama H, Hara A (2025) Advances in bacterial artificial chromosome (BAC) transgenic mice for gene analysis and disease research. Gene 934:149014. https:\/\/doi.org\/10.1016\/j.gene.2024.149014","journal-title":"Gene"},{"key":"510_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/01926230252824851","volume":"30","author":"D Morton","year":"2002","unstructured":"Morton D, Alden CL, Roth AJ, Usui T (2002) The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 30:139\u2013146. https:\/\/doi.org\/10.1080\/01926230252824851","journal-title":"Toxicol Pathol"},{"key":"510_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/01926230490483315","volume":"32","author":"M Okamura","year":"2004","unstructured":"Okamura M, Moto M, Kashida Y, Machida N, Mitsumori K (2004a) Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice. Toxicol Pathol 32:474. https:\/\/doi.org\/10.1080\/01926230490483315","journal-title":"Toxicol Pathol"},{"key":"510_CR18","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00204-004-0589-5","volume":"78","author":"M Okamura","year":"2004","unstructured":"Okamura M, Sumida K, Muto T, Kashida Y, Machida N, Watanabe T, Mitsumori K (2004b) Analysis of gene expression profiles of forestomach tumors in rasH2 mice initiated with N-ethyl-N-nitrosourea. Arch Toxicol 78:688\u2013696. https:\/\/doi.org\/10.1007\/s00204-004-0589-5","journal-title":"Arch Toxicol"},{"key":"510_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1091581812471565","volume":"32","author":"MG Paranjpe","year":"2013","unstructured":"Paranjpe MG, Elbekaei RH, Shah SA, Hickman M, Wenk ML, Zahalka EA (2013) Historical control data of spontaneous tumors in transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice. Int J Toxicol 32:48\u201357. https:\/\/doi.org\/10.1177\/1091581812471565","journal-title":"Int J Toxicol"},{"key":"510_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1293\/tox.2024-0037","volume":"38","author":"ME Pereira Bacares","year":"2025","unstructured":"Pereira Bacares ME, Stevens EL, Laast V, Vemiredi V, Adissu HA, Mense MG (2025) Histopathology of incidental non-neoplastic findings in transgenic CByB6F1-Tg(HRAS)2Jic mice used in toxicity studies. J Toxicol Pathol 38:93\u2013111. https:\/\/doi.org\/10.1293\/tox.2024-0037","journal-title":"J Toxicol Pathol"},{"key":"510_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/300149a0","volume":"300","author":"EP Reddy","year":"1982","unstructured":"Reddy EP, Reynolds RK, Santos E, Barbacid M (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300:149\u2013152. https:\/\/doi.org\/10.1038\/300149a0","journal-title":"Nature"},{"key":"510_CR22","first-page":"1195","volume":"5","author":"A Saitoh","year":"1990","unstructured":"Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, Katsuki M (1990) Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5:1195\u20131200","journal-title":"Oncogene"},{"key":"510_CR23","first-page":"851","volume":"76","author":"T Sekiya","year":"1985","unstructured":"Sekiya T, Prassolov VS, Fushimi M, Nishimura S (1985) Transforming activity of the c-Ha-ras oncogene having two point mutations in codons 12 and 61. Jpn J Cancer Res 76:851\u2013855","journal-title":"Jpn J Cancer Res"},{"key":"510_CR24","doi-asserted-by":"publisher","first-page":"e13619","DOI":"10.1111\/cpr.13619","volume":"57","author":"P Song","year":"2024","unstructured":"Song P, Li X, Chen S, Gong Y, Zhao J, Jiao Y, Dai Y, Yang H, Qian J, Li Y, He J, Tang L (2024) YTHDF1 mediates N-methyl-N-nitrosourea-induced gastric carcinogenesis by controlling HSPH1 translation. Cell Prolif 57:e13619. https:\/\/doi.org\/10.1111\/cpr.13619","journal-title":"Cell Prolif"},{"key":"510_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mc.10045","volume":"34","author":"H Suemizu","year":"2002","unstructured":"Suemizu H, Muguruma K, Maruyama C, Tomisawa M, Kimura M, Hioki K, Shimozawa N, Ohnishi Y, Tamaoki N, Nomura T (2002) Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Mol Carcinog 34:1\u20139. https:\/\/doi.org\/10.1002\/mc.10045","journal-title":"Mol Carcinog"},{"issue":"Suppl","key":"510_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/019262301753178492","volume":"29","author":"N Tamaoki","year":"2001","unstructured":"Tamaoki N (2001) The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol 29(Suppl):81\u201389. https:\/\/doi.org\/10.1080\/019262301753178492","journal-title":"Toxicol Pathol"},{"key":"510_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/ijmm.2024.5448","volume":"55","author":"ML Tornesello","year":"2025","unstructured":"Tornesello ML (2025) TP53 mutations in cancer: molecular features and therapeutic opportunities (review). Int J Mol Med 55:7. https:\/\/doi.org\/10.3892\/ijmm.2024.5448","journal-title":"Int J Mol Med"},{"key":"510_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1293\/tox.2021-0068","volume":"35","author":"H Tsutsumi","year":"2022","unstructured":"Tsutsumi H, Inoue R, Yasuda M, Takahashi R, Suzuki M, Urano K (2022) rasH2 mouse: reproducibility and stability of carcinogenicity due to a standardized production and monitoring system. J Toxicol Pathol 35:19\u201324. https:\/\/doi.org\/10.1293\/tox.2021-0068","journal-title":"J Toxicol Pathol"},{"key":"510_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2131\/jts.31.407","volume":"31","author":"K Urano","year":"2006","unstructured":"Urano K, Suzuki S, Machida K, Sawa N, Eguchi N, Kikuchi K, Fukasawa K, Taguchi F, Usui T (2006) Use of IC tags in short-term carcinogenicity study on CB6F1 TGrasH2 mice. J Toxicol Sci 31:407\u2013418. https:\/\/doi.org\/10.2131\/jts.31.407","journal-title":"J Toxicol Sci"},{"key":"510_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/019262301753178500","volume":"29","author":"T Usui","year":"2001","unstructured":"Usui T, Mutai M, Hisada S, Takoaka M, Soper KA, Mccullough B, Alden C (2001) CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol 29:90\u2013108. https:\/\/doi.org\/10.1080\/019262301753178500","journal-title":"Toxicol Pathol"},{"key":"510_CR31","doi-asserted-by":"publisher","first-page":"1377990","DOI":"10.3389\/ftox.2024.1377990","volume":"6","author":"JL Vahle","year":"2024","unstructured":"Vahle JL, Dybowski J, Graziano M, Hisada S, Lebron J, Nolte T, Steigerwalt R, Tsubota K, Sistare FD (2024) ICH S1 prospective evaluation study and weight of evidence assessments: commentary from industry representatives. Front Toxicol 6:1377990. https:\/\/doi.org\/10.3389\/ftox.2024.1377990","journal-title":"Front Toxicol"},{"key":"510_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2025.06.011","author":"S Xiao","year":"2025","unstructured":"Xiao S, Wu J, Tan K, Zhang S, Dai Y, Wu J, Wu J, Han X, Zheng D, Wang X, Song H, Lu M (2025) p53 mutation-associated prognosis across cancer types underlines hematological malignancy as an applicable cancer type to p53-rescue therapy. Fundam Res. https:\/\/doi.org\/10.1016\/j.fmre.2025.06.011","journal-title":"Fundam Res"},{"issue":"Suppl 1","key":"510_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1289\/ehp.98106s157","volume":"106","author":"S Yamamoto","year":"1998","unstructured":"Yamamoto S, Urano K, Koizumi H, Wakana S, Hioki K, Mitsumori K, Kurokawa Y, Hayashi Y, Nomura T (1998) Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 106(Suppl 1):57\u201369. https:\/\/doi.org\/10.1289\/ehp.98106s157","journal-title":"Environ Health Perspect"},{"key":"510_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13045-024-01631-9","volume":"17","author":"X Yang","year":"2024","unstructured":"Yang X, Wu H (2024) RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms. J Hematol Oncol 17:108. https:\/\/doi.org\/10.1186\/s13045-024-01631-9","journal-title":"J Hematol Oncol"},{"key":"510_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.16153\/j.1002-7777.2019.08.007","volume":"33","author":"Y Yang","year":"2019","unstructured":"Yang Y, Liu S, Lv J, Wang S, Zhang S, Liu Q, Fan C (2019) Research progress of transgenic animal models for preclinical carcinogenicity study of drugs in China. Chin Pharm Aff 33:880\u2013886. https:\/\/doi.org\/10.16153\/j.1002-7777.2019.08.007","journal-title":"Chin Pharm Aff"},{"key":"510_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cac2.12377","volume":"43","author":"H Yang","year":"2023","unstructured":"Yang H, Zhou X, Fu D, Le C, Wang J, Zhou Q, Liu X, Yuan Y, Ding K, Xiao Q (2023) Targeting RAS mutants in malignancies: successes, failures, and reasons for hope. Cancer Commun 43:42\u201374. https:\/\/doi.org\/10.1002\/cac2.12377","journal-title":"Cancer Commun"}],"container-title":["Transgenic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-026-00510-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11248-026-00510-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-026-00510-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:42:14Z","timestamp":1788428534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11248-026-00510-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1007\/s11248-026-00510-y","relation":{},"ISSN":["1573-9368"],"issn-type":[{"value":"1573-9368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}